APA citiranje

Osonoi, T., Tamasawa, A., Osonoi, Y., Ofuchi, K., Katoh, M., & Saito, M. (2019). Canagliflozin Increases Postprandial Total Glucagon-Like Peptide 1 Levels in the Absence of α-Glucosidase Inhibitor Therapy in Patients with Type 2 Diabetes: A Single-Arm, Non-randomized, Open-Label Study. Diabetes Ther.

Citação norma Chicago

Osonoi, Takeshi, Atsuko Tamasawa, Yusuke Osonoi, Kensuke Ofuchi, Makoto Katoh, and Miyoko Saito. "Canagliflozin Increases Postprandial Total Glucagon-Like Peptide 1 Levels in the Absence of α-Glucosidase Inhibitor Therapy in Patients With Type 2 Diabetes: A Single-Arm, Non-randomized, Open-Label Study." Diabetes Ther 2019.

MLA citiranje

Osonoi, Takeshi, et al. "Canagliflozin Increases Postprandial Total Glucagon-Like Peptide 1 Levels in the Absence of α-Glucosidase Inhibitor Therapy in Patients With Type 2 Diabetes: A Single-Arm, Non-randomized, Open-Label Study." Diabetes Ther 2019.